GUANABENZ ACETATE Chemical Properties

Melting point:

227-229℃ (decomposition)

storage temp. 

Keep in dark place,Inert atmosphere,Room temperature

solubility 

H₂O: 11 mg/mL

form 

solid

color 

white

Merck 

14,4558

Stability:

Hygroscopic

Safety Information

Hazard Codes 

Xn

Risk Statements 

22

Safety Statements 

22-36/37/39-45

RIDADR 

UN 2811 6.1/PG 3

WGK Germany 

3

RTECS 

MF0382000

HazardClass 

6.1(b)

PackingGroup 

III

HS Code 

2928002500

Hazardous Substances Data

23256-50-0(Hazardous Substances Data)

MSDS

• Language:English Provider:SigmaAldrich

GUANABENZ ACETATE Usage And Synthesis

Uses

antihypertensive

Uses

α2-adrenergic agonist and IGRS selective ligand

Definition

ChEBI: Guanabenz acetate is a dichlorobenzene. It has a role as a geroprotector.

brand name

Wytensin (Wyeth).

General Description

Guanabenz acetate, [(2,6-dichlorobenzylidene)amino]guanidine monoacetate (Wytensin), is acentral 2-adrenergic agonist that reduces the release of norepinephrinefrom the neuron when stimulated. The effect ofthe drug results in decreased sympathetic tone in the heart,kidneys, and peripheral blood vessels. The drug does not produceorthostatic hypotension.

Biological Activity

α 2 -adrenergic agonist and IGRS (imidazoline I 2 binding site) selective ligand.

Biochem/physiol Actions

Centrally acting α2 adrenoceptor agonist; I2 imidazoline binding site ligand; antihypertensive.

Pharmacokinetics

The oral bioavailability of guanabenz is 70 to 80%. Following an oral dose, the hypotensive effect of guanabenz begins within 1 hour, peaks within 2 to 7 hours, and is diminished within 6 to 8 hours. It has an elimination half-life averaging 4 to 14 hours. The blood pressure response can persist for at least 12 hours. Following IV dosing, guanabenz is distributed into the CNS, with brain concentrations 3 to 70 times higher than concurrent plasma concentrations. Guanabenz is approximately 90% bound to plasma proteins. In patients with hepatic or renal impairment, its elimination half-life may be prolonged.
Guanabenz is metabolized principally by hydroxylation to its inactive metabolite, 4-hydroxyguanabenz, which is eliminated in the urine as its glucuronide (major) and sulfate conjugates. Guanabenz and its inactive metabolites are excreted principally in urine, with approximately 70 to 80% of its oral dose excreted in urine within 24 hours and approximately 10–30% in feces via enterohepatic cycling. Approximately 40% of an oral dose of guanabenz is excreted in urine as 4-hydroxyguanabenz and its glucuronide, and less than 5% is excreted unchanged. The remainder is excreted as unidentified metabolites and their conjugates.

Clinical Use

Overall, the therapeutic applications for guanabenz are similar to those of clonidine and other α2-adrenergic agonists. One advantage for guanabenz is its once-a-day dosing schedule. Guanabenz has been used in diabetic patients with hypertension without adverse effect on the control of or therapy for diabetes, and it has been effective in hypertensive patients with chronic obstructive pulmonary disease, including asthma, chronic bronchitis, or emphysema. Guanabenz has been used alone or in combination with naltrexone in the management of opiate withdrawal in patients physically dependent on opiates and undergoing detoxification. Guanabenz also has been used as an analgesic in a limited number of patients with chronic pain

Side effects

Overall, the frequency of adverse effects produced by guanabenz is similar to that produced by clonidine and the other α2-adrenergic agonists, but the incidence is lower. As with the other centrally active sympatholytics (e.g., clonidine), abrupt withdrawal of guanabenz may result in rebound hypertension, but the withdrawal syndrome symptoms appear to be less severe.

storage

Store at RT

GUANABENZ ACETATE(23256-50-0)Related Product Information

• Imidazolidinyl urea
• Methimazole
• Pyridine hydrochloride
• Chlorphenamine maleate
• Brimonidine Tartrate
• Medetomidine HCl
• Doxazosin mesylate
• A 769662
• Veliparib
• DL-Tetramisole BP(V)98
• Imidazolium salt
• Guanidine acetate
• 4-IMIDAZOLEACETIC ACID HYDROCHLORIDE
• GUANABENZ
• GUANABENZ ACETATE
• AMINOGUANIDINE HYDROCHLORIDE
• GUANABENZ ACETATE USP(CRM STANDARD)